Cargando…

Cancer Metabolism as a New Real Target in Tumor Therapy

Detalles Bibliográficos
Autores principales: Chiaradonna, Ferdinando, Scumaci, Domenica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227542/
https://www.ncbi.nlm.nih.gov/pubmed/34198722
http://dx.doi.org/10.3390/cells10061393
_version_ 1783712547137912832
author Chiaradonna, Ferdinando
Scumaci, Domenica
author_facet Chiaradonna, Ferdinando
Scumaci, Domenica
author_sort Chiaradonna, Ferdinando
collection PubMed
description
format Online
Article
Text
id pubmed-8227542
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82275422021-06-26 Cancer Metabolism as a New Real Target in Tumor Therapy Chiaradonna, Ferdinando Scumaci, Domenica Cells Editorial MDPI 2021-06-05 /pmc/articles/PMC8227542/ /pubmed/34198722 http://dx.doi.org/10.3390/cells10061393 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Chiaradonna, Ferdinando
Scumaci, Domenica
Cancer Metabolism as a New Real Target in Tumor Therapy
title Cancer Metabolism as a New Real Target in Tumor Therapy
title_full Cancer Metabolism as a New Real Target in Tumor Therapy
title_fullStr Cancer Metabolism as a New Real Target in Tumor Therapy
title_full_unstemmed Cancer Metabolism as a New Real Target in Tumor Therapy
title_short Cancer Metabolism as a New Real Target in Tumor Therapy
title_sort cancer metabolism as a new real target in tumor therapy
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227542/
https://www.ncbi.nlm.nih.gov/pubmed/34198722
http://dx.doi.org/10.3390/cells10061393
work_keys_str_mv AT chiaradonnaferdinando cancermetabolismasanewrealtargetintumortherapy
AT scumacidomenica cancermetabolismasanewrealtargetintumortherapy